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Abstract
Background
The lack of information regarding the burden of acute bacterial meningitis in Latin America
leads to a reduction in the estimated incidence rates of the disease, and impairs public health
decisions on the use and follow-up of preventive interventions, particularly, the evaluation of
existing vaccination policies. The use of the real-time PCR in diagnostic routine procedures
has resulted in a substantial increase in confirmed bacterial meningitis cases. However, in
resource-poor countries, these assays are only available in reference laboratories. Sample
transportation to these laboratories is a critical constraint, as it requires specialized, high cost
courier services. To overcome this barrier we evaluated the use of FTATM Elute filter paper
cards for the conservation and processing of samples under normal environmental condi-
tions, as they would be when transported from remote and under-equipped healthcare facili-
ties to the reference centers. A total of 401 samples received in 2015 as part of Sao Paulo’s
national surveillance for routine diagnosis were selected for this study.
Methods
The sensitivity and specificity of real-time PCR were evaluated using fresh serum and cere-
brospinal fluid (CSF) samples processed using our laboratory’s standard DNA extraction,
and processing the same samples after being dried and stored on FTATM card, and DNA
extracted following the manufacturer’s instructions.
Results
The sensitivities for detection of Neisseria meningitidis, Streptococcus pneumoniae, and
Haemophilus influenzae from CSF dried and stored on FTATM cards were 98%, 92%, and
100%, respectively, and with serum samples were 73%, 88%, and 100%, respectively.
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When compared to our laboratory’s standard methodology, results showed high concor-
dance, with Kappa index ranges of 0.9877–1.00 for CSF, and 0.8004–1.00 for serum
samples.
Conclusion
The use of FTATM cards for CSF and serum conservation and transport represents a rapid,
reliable, and cost-effective alternative that will allow obtaining valuable epidemiological infor-
mation that would otherwise be lost.
Introduction
Acute Bacterial Meningitis (ABM) is one of the most severe diseases affecting mostly children
and adolescents, and remains a serious public health concern. It is estimated that up to 1.2 mil-
lion cases and 135,000 deaths occur annually worldwide, and 10–20% of survivors are left with
life-altering disabilities [1–3]. Three bacteria: Streptococcus pneumoniae (Spn), Neisseria menin-
gitidis (Nm), and Haemophilus influenzae (Hi) are responsible for over 80% of ABM diagnosed
outside the neonatal period [4]. There are currently a number of protein-polysaccharide conju-
gated vaccines that are effective against these pathogens when administered through childhood
immunization programs [5–10], but their elevated cost presents a challenge in low and middle-
income countries, where it is necessary to demonstrate their benefit to justify this investment.
To this aim, the implementation of a comprehensive surveillance system encompassing epide-
miological and laboratory information, and the availability of reliable diagnostic methods that
allow confirmation of the etiological agent, are imperative to prove their cost-effectiveness.
In Latin America, a region that, historically, led the way on the implementation of a
regional Expanded Program of Immunizations [11], all countries, with the exception of Haiti,
had introduced the Hib conjugate vaccine by the end of 2006 [12], and currently 35 countries
incorporate PCV10 or PCV13 in their childhood vaccination schedule. However, the lack of
information regarding the burden of disease and circulating Nm strains makes the implemen-
tation of meningococcal vaccines in the region a low priority. To date, Brazil, Chile, and
Argentina have included one of the available meningococcal conjugate vaccine in their sched-
ules. These three countries have efficient surveillance systems and strong laboratory capacities
that have provided the information needed to support the decision. With a few exceptions,
even before vaccine implementation, the majority of countries in the region reported few to no
cases of Hi, Spn and, particularly, Nm. Information available through SIREVA II, a passive lab-
oratory-based network that collected information on isolates typed by the National Reference
Laboratories from 1997 to 2012 [13–21], was valuable in guiding public health decisions
regarding the use of H. influenzae type b (Hib) and pneumococcal vaccines [22–24], yet insuf-
ficient to provide evidence with regard to meningococcal vaccination [25]. Moreover, the
impact of the pneumococcal vaccine in many low-income countries in Latin America is only
assessed indirectly due to the difficulties in isolating the pathogen [26].
Most hospitals in Latin America have the facilities to conduct basic bacteriological analyses,
but culture positivity rates are very low due to the use of antibiotics prior to sample collection,
and to delay in transporting samples to the laboratory. The use of rapid diagnostic tests is
often hampered by their high cost, short shelf-life, specific conservation conditions, and the
skill of the laboratory technician to correctly interpret results [27]. The difficulties encountered
in the isolation and characterization of bacteria directly affects the quality of data reported to
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epidemiological surveillance, as many cases of ABM are recorded as unknown etiology, or sim-
ply not informed due to the lack of laboratory confirmation This leads to a reduction in the
estimated incidence rates of the disease, which affects both public health decision making in
the use of preventive interventions in the population, and the evaluation of existing vaccina-
tion policies.
Real-time PCR assays directly from clinical samples, i.e. serum and cerebrospinal fluid
(CSF), have been widely used in diagnosis of ABM caused by Hi, Spn, and Nm, and proven to
be highly sensitive, specific, and reproducible even after the administration of the antibiotics
[28–32]. The use of the real-time PCR in diagnostic routine procedures has contributed to sub-
stantial increase in the number of confirmed ABM cases [29–30]. However, in resource-poor
countries, these assays can only be conducted in reference laboratories that have the necessary
infrastructure, equipment, and trained personnel. Sample transportation to these laboratories
needs to be done within a very small timeframe, and requires specific biosafety measures and
preservation conditions that can only be ensured by specialized, and costly, courier services.
The use of filter paper for the long-term conservation and diagnosis of infections has
proved to be a good alternative in settings with limited laboratory facilities [33–35]. Moreover,
Spn and Hi have successfully been detected from dry blood and CSF samples [36–40], but
there is insufficient data on the use of this technique for the detection of Nm.
In this study, we aim to evaluate the use of FTATM Elute filter paper cards for the conserva-
tion, and real-time PCR detection of Nm, Spn, and Hi from CSF and serum samples, and pro-
vide evidence of the applicability of this technique for the transport and processing of samples
from remote and under-equipped healthcare facilities to the reference centers.
Materials and methods
Ethics statement
This study was approved by the Ethical Committee of Instituto Adolfo Lutz, by Brazil’sNa-
tional Committee for Ethics in Research (Comissão Nacional de E´tica em Pesquisa, CONEP,
protocol number CAAE4549613.0.0000.0059) and the Pan-American Health Organization
Ethics Review Committee.
Samples
We analyzed CSF and serum samples from suspected cases of bacterial meningitis from public
health units in São Paulo city, Brazil, between March and November 2015. A total of 401 sam-
ples were received as part of Sao Paulo’s national surveillance for routine diagnosis, and were
selected by order of arrival to the laboratory. Samples were anonymized and identified by a
unique number before access, and no clinical or personal data were required for this study.
DNA extraction
Each sample was tested simultaneously according two processing protocols (Fig 1). On day 1,
200 μL of each sample were used in automated process for DNA extraction by Roche MagNA
Pure LC 2.0 equipment according to the manufacturer’s instructions. Additionally, 40 μL of
each sample were impregnated on the FTATM Elute Card (GE Healthcare Life Sciences) [41],
dried at room temperature for 3 hours, and stored for seven days at room temperature. On the
7th day after impregnation, two 3 mm-discs were punched from the center of each card using
Uni-CoreTM punch (GE Healthcare Lifesciences) and placed in 1.5 mL microcentrifuge tube.
To prevent cross-contamination between samples, the punch was cleaned with 70% ethanol,
dried with tissue paper, and punched on clean piece of filter paper three times. The punched
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discs were washed with 1 mL of sterile water and pulse vortexed three times for a total of 5 sec-
onds, followed by centrifugation at 10,000 rpm for 10 seconds. Water was carefully removed
using an automatic pipette, and 30 μL of molecular biology grade water were added to the
tube, which was incubated in a heat block set at 98˚C for 30 minutes. After pulse vortexing 60
times (one pulse/second) and centrifugation at 10,000 rpm for 30 seconds, discs were removed
from the elution tube and discarded, thus obtaining the DNA.
Real-time PCR assays
Extracted DNA from MagNA Pure were all analyzed by real-time PCR on day 1, while extracted
DNA from FTATM card were all analyzed on day 7. Two different real-time PCR assays were
performed for both extractions: (i) Triplex for detecting Nm (ctrA gene), Spn (lytA gene), and
Hi (hpd gene), and (ii) Singleplex for the detection of human RNase P gene.
Assays were performed in a final volume of 25 μL using TaqMan Universal Master Mix
(Applied Biosystems) with 5 μL extracted DNA and specific primers and probes described pre-
viously [29, 31]. All reactions were performed in duplicate on Applied Biosystems 7500 real-
time PCR system employing the following cycling conditions: 50˚C for 2 minutes, 95˚C for 10
minutes followed by 45 cycles of 95˚C for 15 seconds and 60˚C for 1 min.
A result was considered positive when presented a cycle threshold value (Ct) less than or
equal to 38 (Ct 38) and negative when Ct = 0 or Ct 39. Samples with positive results for
Fig 1. Processing algorithm of samples.
doi:10.1371/journal.pone.0172794.g001
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Nm or Hi were tested in real-time PCR reactions to identify genogroups A, B, C, W, Y, and X,
and genotypes a, b, c, d, e, and f using oligonucleotides described by Mothershed, and Maar-
oufi [42, 43], respectively.
Data analysis
The sensitivity and specificity of real-time PCR performed on fresh samples processed by auto-
mated extraction MagNA Pure (gold standard), and the same samples dried on the FTATM
card were calculated using data from 2x2 tables. The agreement between the tests was assessed
using Kappa index and its 95% confidence interval (CI), and classified according to Landis
and Koch (1977) on: Kappa index < 0 = no agreement; Kappa between 0 to 0.19 = low agree-
ment; Kappa between 0.20 to 0.39 = fair agreement; Kappa between 0.40 0.59 = moderate
agreement; Kappa between 0.60 to 0.79 = substantial agreement; Kappa between 0.80 to
1.00 = high concordance.
Results
The positivity and average Cts values obtained by triplex real-time PCR using DNA extracted
by automated system (MagNA Pure) or directly from the FTATM card are shown in Table 1.
The test using DNA extracted from FTATM showed higher Ct values that which employed
DNA extracted automatically, with a difference in Ct value of 2 to 5 cycles.
The sensitivity and specificity of triplex real-time PCR assay using purified DNA from
FTATM card are shown on Tables 2 and 3. In CSF samples, we observed that the real-time PCR
assay employing the FTATM card or MagNA Pure showed high correlation (Kappa = 0.9624,
CI 95% 0.9259–0.9989) with a sensitivity of 96% and specificity of 100%. For detection of Nm,
Spn, and Hi, the sensitivity was 98%, 92% and 100%, respectively, with high concordance
(Kappa between 0.9877 and 1.00) (Table 2).
Table 1. Real-time PCR positivity for detection of Nm, Spn, and Hi in clinical samples received as part of Sao Paulo’s national surveillance for rou-
tine diagnosis analysis.
Sample type N˚. of positives (Ct average±SD) N˚. of negatives Total (n = 401)
Nm Spn Hi
Roche FTATM Roche FTATM Roche FTATM Roche FTATM
CSF 55 (23.6±5.2) 54 (28.3±4.6) 39 (23.4±5.8) 36 (26.2±5.2) 16 (22.7±6.2) 16 (27.6±6.1) 103 107 213
Serum 48 (28.9±6.3) 35 (30.6±4.8) 33 (29.1±5.8) 29 (31.8±5.7) 2 (25.5±5.5) 2 (30.5±4.5) 105 122 188
Nm, Neisseria meningitidis; Spn, Streptococcus pneumoniae; Hi, Haemophilus influenzae; Ct, cycle threshold; SD, standard deviation; CSF, cerebrospinal
fluid. In parentheses is the average of Ct obtained in real-time PCR assay using DNA extracted by automated method (Roche MagNAPure LC 2.0) or by
filter paper card FTATM.
doi:10.1371/journal.pone.0172794.t001
Table 2. Values of sensitivity, specificity and Kappa index of real-time PCR assay using purified DNA from CSF impregnated on FTATM card.
Nm + Spn + Hi Nm Spn Hi
Sensitivity 96% 98% 92% 100%
Specificity 100% 100% 100% 100%
Kappa 0.9624 0.9877 0.9515 1.0
CI 95% [0.9259–0.9989] CI 95% [0.9636–1.0] CI 95% [0.8970–1.0] CI 95% [1.0–1.0]
Nm, Neisseria meningitidis; Spn, Streptococcus pneumoniae; Hi, Haemophilus influenzae; CI, confidence interval; sensitivity and specificity was calculated
considering the DNA extracted by the automated system Roche MagNA Pure LC 2.0 as gold standard.
doi:10.1371/journal.pone.0172794.t002
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In serum samples, the sensitivities were respectively 73%, 88%, and 100% for the detection
of Nm, Spn, and Hi. Both methods (FTATM and MagNA Pure) showed excellent agreement of
results, expressed by Kappa index between 0.8004 and 1.00 (Table 3). All CSF and serum sam-
ples processed by the FTATM card or by automated DNA extraction system were positive for
the presence of human RNase P gene.
Real-time PCR assays from DNA extracted using the MagNA Pure system were able to
identify 91.3% (94/103) of Nm genogroups (Nm B, n = 23; Nm C, n = 63; Nm W, n = 6; Nm Y,
n = 2) and 66.7% (12/18) of Hi genotypes (Hi a, n = 5; Hi b, n = 7). Real-time PCR assays from
DNA extracted using FTATM card were able to identified 87.6% (78/89) of Nm genogroups
(Nm B, n = 18; Nm C, n = 54; Nm W, n = 4; Nm Y, n = 2) and 61.1% (11/18) of Hi genotypes
(Hi a, n = 4; Hi b, n = 7).
Discussion
In this study, we evaluated the use of FTATM cards in the diagnosis of infections caused by
three of the major causative agents of bacterial meningitis by real-time PCR as an approach for
the transport and processing of biological samples. We demonstrated that standardized rou-
tine real-time PCR assays performed on CSF and serum samples preserved dried on FTATM
filter paper up to seven days maintain a level of sensitivity comparable to when performed
directly on fresh biological samples. The 7 days interval for testing was chosen as it was consid-
ered to be equivalent to the maximum period for the arrival of impregnated clinical samples to
the reference laboratory when sent through the regular mail service.
In the initial phase of this study, we found that there was no difference in real-time PCR
positivity when we used DNA extracted from filter paper discs after 1 day or 7 days of impreg-
nation of the sample on the card, compared to the results obtained with DNA extracted from
the MagNA Pure. We also found that positivity of real-time PCR for Nm, Spn, and Hi detec-
tion was higher when we used two 3 mm-discs from FTATM card (94%) in the DNA extraction
process instead of one disc (82%) (S1 Table).
Similar studies showed good performance using filter paper in molecular diagnosis of infec-
tions caused by Spn or Hi. Peltola et al [38] obtained a sensitivity of 92% and 70% for detection
of Spn, and Hi, respectively, using impregnated CSF on filter paper and real-time PCR. Quan-
titative real-time PCR assays for detection of Spn and Streptococcus suis in CSF preserved on
filter paper showed a sensitivity and specificity of 80% and 100% respectively when compared
to PCR assays using DNA extracted from liquid CSF [36]. Selva et al [39] demonstrated that
use of impregnated blood samples on filter paper resulted in 4-fold increase in Spn or Hi detec-
tion compared to standard culture. Recently, Iroh Tam et al [37] showed a sensitivity of 62.5%
of real-time PCR assay for detection of Spn in impregnated blood samples on FTATM filter
paper compared to culture.
Table 3. Values of sensitivity, specificity and Kappa index of real-time PCR assay using purified DNA from serum impregnated on FTATM card.
Nm + Spn + Hi Nm Spn Hi
Sensitivity 80% 73% 88% 100%
Specificity 100% 100% 100% 100%
Kappa 0.8126 0.8004 0.9228 1.0
CI 95% [0.7276–0.8976] CI 95% [0.6957–0.9051] CI 95% [0.8480–0.9976] CI 95% [1.0–1.0]
Nm, Neisseria meningitidis; Spn, Streptococcus pneumoniae; Hi, Haemophilus influenzae; CI, confidence interval; sensitivity and specificity was calculated
considering the DNA extracted by the automated system Roche MagNA Pure LC 2.0 as gold standard.
doi:10.1371/journal.pone.0172794.t003
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For detection of Nm by molecular techniques using filter paper cards there is insufficient
data. The study conducted by Elliot [36] analyzed the presence of Nm, Spn, and S. suis in
impregnated CSF on filter paper by real-time PCR, but none was positive for Nm. In contrast,
our study indicated that use of the FTATM card in the real-time PCR resulted in high levels of
detection of Nm in CSF and serum. A recent study also demonstrated that Nm can be detected
from nasopharyngeal swab samples impregnated in FTATM cards with sensitivity comparable
to conventional culture [44]. We also showed that paper filter card may be used for molecular
identification of Nm serogroups or Hi serotypes, hence providing valuable information on cir-
culating strains, emergence of non-vaccine serotypes, and facilitating the detection of out-
breaks. This is of particular relevance for meningococcal disease, for which special control
measures are needed to control the spread of the infection among the patient’s close contacts,
yet the administration of antimicrobial preventive treatment only occurs once the case is con-
firmed by the laboratory.
In our study we found that the performance of serum samples impregnated on filter paper
was lower than CSF, probably due to the presence of PCR inhibitors that were not efficiently
removed and/or inactivated by the chemical reagents present in the card. In addition, samples
with low initial bacterial load would probably not be detected in real-time PCR assays using
the filter paper, as the FTATM card employs considerably smaller amount of sample for DNA
extraction (40 μL for impregnation, and two 3-mm discs for DNA extraction) compared to the
automated DNA extraction system (200 μL). This was reflected in 2 to 4 units increase on the
Ct values obtained in real-time PCR using DNA extracted from FTATM compared with auto-
mated DNA extraction. In the CSF samples, the average Ct value was 23.4±5.6 and 27.5±5.2
using DNA extracted from the MagNA Pure and FTATM, respectively. In serum, average Ct
was 28.9 ± 6.1 with the use of MagNa Pure and 31.1 ± 5.3 with use of FTATM. From the 17 neg-
ative serum samples with use of the FTATM card, 13 showed high Ct values (greater than 35) in
the real-time PCR with DNA extracted by MagNA Pure; the other 4 samples resulted in Ct
value of 34.
The high concordance between the results of real-time PCR using MagNA Pure at Day 1
and FTATM at Day 7 indicates that the impregnated sample can be preserved at room tempera-
ture for at least one week. Other studies have shown that different types of biological materials
such as CSF, whole blood and serum can be stored for long periods on filter paper for diagnos-
tic and/or identification purposes [38, 44, 45].
Although culture is regarded as the gold standard for the diagnostic of bacterial meningitis,
the sensitivity of real-time PCR has been widely demonstrated, and the technique is used in
national and international reference laboratories for diagnostic and surveillance purposes in
lieu of culture. For our samples, culture results were available only for 40 samples, as this infor-
mation is not routinely reported from the hospitals to our laboratory. For those samples for
which culture results could be obtained, 16 Nm, 17 Spn and 7 Hi, there was a 100% concor-
dance with the results obtained using real-time PCR on impregnated samples. Moreover, Nm
serogroups and Hi serotypes were also concordant.
Another limitation in our study was the low number of Hi positive samples due to the low
prevalence of Hi infections in our population. However, our results demonstrate that it is pos-
sible to identify and genotype this pathogen from samples preserved on FTATM cards, thus
making this a valid methodology for routine surveillance and vaccine evaluation.
The use of FTATM cards for preservation and transport of biological samples can signifi-
cantly reduce the costs and facilitate the logistic of sending samples from healthcare facilities
to reference laboratories. In low and middle income countries, where the etiological agent is
rarely confirmed by standard bacteriology techniques, the use of real-time PCR for the detec-
tion of Nm, Spn, and Hi has the potential to significantly increase the number of confirmed
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cases for surveillance purposes and public health decision-making. Moreover, we demon-
strated that it is possible to type both Nm and Hi. Serotying of Spn, although possible, is ham-
pered by the amount of DNA obtained from the cards, and the fact Spn serotyping requires
various sequential reactions. However, in certain situations, when there is a limited number of
serotypes of interest (e.g. outbreak investigation, or vaccine failure against a specific serotype)
it should be possible to obtain this information also from dried samples. For countries needing
to evaluate vaccine impact, collect information to plan future interventions, or monitoring of
current ones, the use of FTATM cards can overcome the limitation of poor laboratory confir-
mation rates. The use of a commercial system for the storage of biological samples guarantees
that the product has been adequately trialed and tested for its purpose, and that it has passed
the necessary quality controls to ensure consistent performance. The FTATM cards are, to our
knowledge, the only commercial system available for long-term DNA storage, and are easily
available throughout Latin America. Although the costs of FTATM cards paired with the use
of molecular techniques can be perceived as expensive, it presents the advantage that DNA
extraction and purification can be done without the use of commercial kits, which correspond
to 50–60% of the final cost. Additionally, the system eliminates the need for a specialized trans-
port, which is an important economic and logistic limiting factor when sending biological
material to reference laboratories. Last but not least, the economic cost need to be measured
against the long-term gains that an accurate laboratory-based surveillance system for invasive
bacterial diseases in low and middle income countries could represent in terms of quality of
life for vulnerable populations.
In summary, the use of FTATM cards for serum and CSF conservation and transport repre-
sents a rapid, reliable, and cost-effective alternative that will allow obtaining valuable epidemi-
ological information that would otherwise be lost.
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S1 Table. Real-time PCR positivity for detection of Nm, Spn, and Hi using DNA extracted
by filter paper card FTATM (one or two 3 mm discs) after 1 day or 7 days of impregnation
of the sample on the card. Nm, Neisseria meningitidis; Spn, Streptococcus pneumoniae; Hi,
Haemophilus influenzae. In parentheses is the positivity of real-time PCR assay using DNA
extracted by FTATM card compared to results obtained with DNA extracted from automated
system Roche MagNA Pure LC 2.0.
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